Page last updated: 2024-09-02

fingolimod hydrochloride and Central Nervous System Disease

fingolimod hydrochloride has been researched along with Central Nervous System Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Al Malik, YM1
Chauvet, P; Coiteux, V; Gauthier, J; Magro, L; Varlet, P; Vermersch, P; Yakoub-Agha, I1
Amemiya, H; Fujino, M; Funeshima, N; Kimura, H; Kitazawa, Y; Li, XK; Suzuki, S1

Other Studies

3 other study(ies) available for fingolimod hydrochloride and Central Nervous System Disease

ArticleYear
Isolated neurosarcoidosis mimicking multiple sclerosis.
    Neurosciences (Riyadh, Saudi Arabia), 2020, Volume: 25, Issue:5

    Topics: Adult; Central Nervous System Diseases; Cerebellum; Diagnostic Errors; Fingolimod Hydrochloride; Humans; Immunologic Factors; Infliximab; Magnetic Resonance Imaging; Male; Meninges; Multiple Sclerosis, Relapsing-Remitting; Neuroimaging; Sarcoidosis; Spinal Cord

2020
Successful treatment with fingolimod of graft-versus-host disease of the central nervous system.
    Blood advances, 2018, 01-09, Volume: 2, Issue:1

    Topics: Aged; Allografts; Central Nervous System Diseases; Fingolimod Hydrochloride; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Receptors, Lysosphingolipid; Treatment Outcome

2018
Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1

    Topics: Animals; Apoptosis; Central Nervous System; Central Nervous System Diseases; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; T-Lymphocytes

2003
chemdatabank.com